SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-182509
Filing Date
2014-05-05
Accepted
2014-05-05 16:24:34
Documents
5
Period of Report
2014-04-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d719979d8k.htm 8-K 24145
2 EX-10.1 d719979dex101.htm EX-10.1 60760
3 EX-10.2 d719979dex102.htm EX-10.2 60860
4 EX-10.3 d719979dex103.htm EX-10.3 60847
5 EX-10.4 d719979dex104.htm EX-10.4 60794
  Complete submission text file 0001193125-14-182509.txt   268707
Mailing Address 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615
Business Address 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615 (919) 862-1000
SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

IRS No.: 943267443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23265 | Film No.: 14813769
SIC: 2834 Pharmaceutical Preparations